COPAXONE LFA Trademark

Trademark Overview

On Wednesday, July 25, 2012, a trademark application was filed for COPAXONE LFA with the United States Patent and Trademark Office. The USPTO has given the COPAXONE LFA trademark a serial number of 85686062. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 2, 2014. This trademark is owned by Teva Pharmaceutical Industries Ltd.. The COPAXONE LFA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis
copaxone lfa

General Information

Serial Number85686062
Word MarkCOPAXONE LFA
Filing DateWednesday, July 25, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 2, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 31, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceutical Industries Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTeva Pharmaceutical Industries Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Monday, June 2, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 2, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, November 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2013EXTENSION 1 GRANTED
Wednesday, October 2, 2013EXTENSION 1 FILED
Wednesday, November 6, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2013TEAS EXTENSION RECEIVED
Tuesday, April 30, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 26, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 22, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 19, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 19, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 14, 2012ASSIGNED TO LIE
Tuesday, December 11, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 14, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 14, 2012NON-FINAL ACTION E-MAILED
Wednesday, November 14, 2012NON-FINAL ACTION WRITTEN
Wednesday, November 14, 2012ASSIGNED TO EXAMINER
Tuesday, July 31, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 28, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

copaxone multiple sclerosis treatment medicine preparation human pharmaceutical